Boosting BMP signaling while blocking TGF-β1 substantially increased polyfunctionality, while suppressing expression of exhaustion-related molecules and maintained the tumor killing ability of CD8 + T cells, enhanced tumor control in mice, and boosted exhausted T-cell responses to ICI therapy [15]. The gene discussed is CD8A; the disease is neoplasm.